Fortress Biotech (FBIOP) News Today → Next President (Not Trump. Not Biden.) (From The Freeport Society) (Ad) Free FBIOP Stock Alerts $16.67 +0.32 (+1.96%) (As of 05/17/2024 ET) Add Compare Share Share HeadlinesStock AnalysisChartCompetitorsDividendFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisChartCompetitorsDividendFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 16 at 12:06 AM | investorplace.comFBIO Stock Earnings: Fortress Biotech Beats EPS, Misses Revenue for Q1 2024May 15, 2024 | washingtonpost.comFortress Biotech: Q1 Earnings SnapshotApril 23, 2024 | seekingalpha.comFBIOP Fortress Biotech, Inc. 9.375% CUM PFD AMarch 28, 2024 | investorplace.comFBIO Stock Earnings: Fortress Biotech Beats EPS, Beats Revenue for Q4 2023March 21, 2024 | finance.yahoo.comJourney Medical Corporation Reports Full-Year 2023 Financial Results and Recent Corporate HighlightsMarch 18, 2024 | finance.yahoo.comCheckpoint Therapeutics Announces Appointment of Accomplished Life Sciences Executive Amit Sharma, M.D. to Board of DirectorsMarch 15, 2024 | markets.businessinsider.comAnalysts Offer Insights on Healthcare Companies: Fortress Biotech (FBIO) and Phreesia (PHR)February 22, 2024 | benzinga.comFortress Biotech Stock (NASDAQ:FBIO) Insider TradesFebruary 22, 2024 | benzinga.comFortress Biotech Stock (NASDAQ:FBIO), Short Interest ReportFebruary 17, 2024 | finance.yahoo.comInsider Stock Buying Reaches US$3.06m On Fortress BiotechFebruary 13, 2024 | msn.comFortress Biotech, Inc. 9.375% CUM RED PER PREF SER A USD25.00 goes ex dividend tomorrowFebruary 2, 2024 | stockhouse.comLindsay Rosenwald’s Fortress Bio (NASDAQ: FBIO) Spotlight on 2024 Milestones from SubsidiariesFebruary 2, 2024 | finance.yahoo.comLindsay Rosenwald’s Fortress Bio (NASDAQ: FBIO) Spotlight on 2024 Milestones from SubsidiariesJanuary 3, 2024 | finance.yahoo.comFortress Biotech Announces Closing of $11 Million Registered Direct Offering Priced At-the-Market Under Nasdaq RulesJanuary 3, 2024 | sg.finance.yahoo.comFortress Biotech Inc (CNB1.SG)December 29, 2023 | markets.businessinsider.comNasdaq Down Over 100 Points; Fortress Biotech Shares PlummetDecember 29, 2023 | marketwatch.comFortress Biotech Shares Drop After Offering Gets PricedDecember 29, 2023 | msn.comFortress Biotech drops on plans to issue 3.3M sharesDecember 29, 2023 | markets.businessinsider.comFortress Biotech Announces Pricing Of Registered Direct Offering - Quick FactsDecember 13, 2023 | finance.yahoo.comAnalysts Expect Breakeven For Fortress Biotech, Inc. (NASDAQ:FBIO) Before LongDecember 7, 2023 | msn.comOrganovo, Fortress Biotech among healthcare moversNovember 28, 2023 | morningstar.comFortress Biotech Inc FBIONovember 16, 2023 | finance.yahoo.comInsider Buying: President, CEO & Chairman, 10% Owner ROSENWALD LINDSAY A MD Acquires Shares ...November 15, 2023 | finanznachrichten.deFortress Biotech, Inc.: Fortress Biotech Reports Third Quarter 2023 Financial Results and Recent Corporate HighlightsNovember 15, 2023 | finanznachrichten.deFortress Biotech, Inc.: Fortress Biotech Announces Closing of $10.0 Million Public OfferingNovember 14, 2023 | finance.yahoo.comFortress Biotech Announces Closing of $10.0 Million Public OfferingNovember 14, 2023 | finance.yahoo.comMustang Bio Reports Third Quarter 2023 Financial Results and Recent Corporate HighlightsNovember 14, 2023 | finance.yahoo.comFortress Biotech Reports Third Quarter 2023 Financial Results and Recent Corporate HighlightsNovember 10, 2023 | marketwatch.comFortress Biotech Shares Plumb New Lows After Equity OfferingNovember 10, 2023 | msn.comWhy Fortress Biotech (FBIO) Shares Are Getting HammeredNovember 10, 2023 | finance.yahoo.comFortress Biotech Announces Pricing of $10.0 Million Public OfferingNovember 9, 2023 | finance.yahoo.comFortress Biotech Announces Launch of Proposed Public OfferingNovember 7, 2023 | finance.yahoo.comJourney Medical Corporation Reports Third Quarter 2023 Financial Results and Recent Corporate HighlightsNovember 2, 2023 | marketbeat.comTrading was temporarily halted for "FBIOP" at 09:11 AM with a stated reason of "LULD pause."November 2, 2023 | msn.comFortress Biotech (FBIO) Price Target Increased by 489.01% to 45.90October 5, 2023 | finance.yahoo.comFortress Biotech to Present at ROTH MKM 2023 Healthcare Opportunities ConferenceOctober 5, 2023 | msn.comFortress Biotech (FBIO) Price Target Increased by 6.11% to 7.79October 2, 2023 | finance.yahoo.comCheckpoint Therapeutics Announces Exercise of Warrants for $11.13 Million in Gross ProceedsSeptember 6, 2023 | finance.yahoo.comCheckpoint Therapeutics to Present at H.C. Wainwright 25th Annual Global Investment ConferenceSeptember 2, 2023 | thestreet.comFortress Biotech Inc. 9.375% Series A Cumulative Redeemable Perpetual Preferred StockAugust 21, 2023 | marketbeat.comTrading was temporarily halted for "FBIOP" at 10:08 AM with a stated reason of "LULD pause."August 18, 2023 | marketbeat.comTrading was temporarily halted for "FBIOP" at 09:08 AM with a stated reason of "LULD pause."August 17, 2023 | marketbeat.comTrading was temporarily halted for "FBIOP" at 02:08 PM with a stated reason of "LULD pause."August 15, 2023 | msn.comCantor Fitzgerald Reiterates Fortress Biotech (FBIO) Overweight RecommendationAugust 14, 2023 | finance.yahoo.comCheckpoint Therapeutics Reports Second Quarter 2023 Financial Results and Recent Corporate HighlightsAugust 11, 2023 | finance.yahoo.comAvenue Therapeutics Reports Second Quarter 2023 Financial Results and Recent Corporate HighlightsAugust 3, 2023 | finance.yahoo.comFortress Biotech to Present at the BTIG Virtual Biotechnology Conference 2023July 31, 2023 | finance.yahoo.comMustang Bio Announces Amendment and Closing of Strategic Manufacturing Partnership Transaction with uBriGene (Boston) BiosciencesJuly 25, 2023 | finance.yahoo.comAvenue Therapeutics Announces Agreement with the FDA on the Study Design and Analysis Approach of the Phase 3 Safety Study for IV TramadolJuly 11, 2023 | finance.yahoo.comJourney Medical Corporation Announces Positive Topline Results from its Two Phase 3 Clinical Trials (MVOR-1 and MVOR-2) Evaluating DFD-29 for the Treatment of Papulopustular Rosacea in Adults Get Fortress Biotech News Delivered to You Automatically Sign up to receive the latest news and ratings for FBIOP and its competitors with MarketBeat's FREE daily newsletter. Email Address Urgent Nvidia Warning (Ad)Could Steve Job's 'Final Prophecy' Make You Rich? Just before he died, Steve Jobs issued a "Final Prophecy" that's now coming true... and making some people rich. In one recent 90-day stretch, 50 companies related to Jobs' "Final Prophecy" soared by 100% or more. What was Steve Jobs' last big prediction, and how can you get in on it? Professor Joel Litman explains everything... including the surprising group of stocks moving higher, and his No. 1 favorite stock in this space. Click here to access… FBIOP Media Mentions By Week FBIOP Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. FBIOP News Sentiment▼-0.630.42▲Average Medical News Sentiment FBIOP News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. FBIOP Articles This Week▼21▲FBIOP Articles Average Week Get Fortress Biotech News Delivered to You Automatically Sign up to receive the latest news and ratings for FBIOP and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Alpha Tau Medical News Artelo Biosciences News BriaCell Therapeutics News eFFECTOR Therapeutics News GeoVax Labs News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:FBIOP) was last updated on 5/19/2024 by MarketBeat.com Staff From Our PartnersCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingUrgent Nvidia WarningAltimetryShocking $16T Elon Musk Crypto LeakCrypto 101 MediaNext President (Not Trump. Not Biden.)The Freeport SocietyDems have chosen Biden replacement?Paradigm Press41 banks launch ‘crypto dollar’Stansberry ResearchMost important medical advance in 100 yearsThe Oxford Club4 Cryptos BETTER than BitcoinTrue Market Insiders Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Fortress Biotech, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.